COSMOS Pharmaceutical Intangible Assets

The latest intangible assets for 3349.T is $930M as of May 2026. That compares with $450M in the prior-year period — up 109.2% year over year. Investors often review this figure alongside COSMOS Pharmaceutical's historical trend and sector peers before judging valuation or financial health.

Over the past year, 3349.T's intangible assets moved from $450M to $930M — a 109.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in COSMOS Pharmaceutical's operating scale or balance-sheet position.

A intangible assets figure of $930M for 3349.T is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 3349.T's intangible assets ($930M), review year-over-year change from $450M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.